Clinical Trials Directory

Trials / Completed

CompletedNCT01463358

Prevention of Syncope by Cardiac Pacing in Patients With Bifascicular Block

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
101 (actual)
Sponsor
Boston Scientific Corporation · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Study Objective The purpose of this study is to evaluate the efficacy of bradycardia pacing with respect to patient symptoms in patients with bifascicular block and syncope of unexplained origin.

Detailed description

Primary endpoint First occurrence of a composite of Syncope of any origin OR Presyncopal episode with documented cardioinhibitory origin OR Atrioventricular block of any degree; all associated with patient symptoms Design: * Randomized, prospective, single blinded, two parallel arms * Treatment group : DDD60 - programmed in DDD mode / 60 lower limit * Control Group: DDI30 - programmed in DDI mode / 30 lower limit * Randomization type: block randomization: Block size: 4, allocation ratio 1:1 Sample: 100 patients Population * Patients with bifascicular block with at least one syncopal episode within the last 6 months preceding enrollment. * Patients should be negative to a series of pre-enrollment screening in order to exclude: * Brady-tachy syndrome, vasovagal syncope or carotid sinus syndrome, atrial fibrillation, inducible AV block * Ejection fraction \>=40% * Mean nocturnal heart rate \>=35 bpm

Conditions

Interventions

TypeNameDescription
DEVICEDDD60 (INSIGNIA® pacing systems Guidant (Boston Scientific)pacing in DDD60 is supposed to prevent events of syncope, presyncope of cardioinhibitory origin and symptom associated to av block
DEVICEDDD60 (INSIGNIA® pacing systems Guidant (Boston Scientific)pacing in DDDI30 is supposed to act as a safety backup upfront to episodes of syncope, presyncope or AV block, but not supposed to reduce symptoms.

Timeline

Start date
2005-03-01
Primary completion
2011-02-01
Completion
2011-05-01
First posted
2011-11-01
Last updated
2021-04-19
Results posted
2021-04-19

Locations

12 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT01463358. Inclusion in this directory is not an endorsement.